Home » Newsletters » BioWorld

BioWorld

Aug. 2, 1993

View Archived Issues

SKB TO MARKET THERATECH'S TESTOSTERONE PATCH

REGENERON FILES FOR OFFERING

APPOINTMENTS AND ADVANCEMENTS

TELOR BEGINS PHASE II TRIALS

NEW WAY TO INHIBIT GENE EXPRESSION

HOUSTON BIOTECH DEBUTS WITH $3.3 MILLION IPO

ORPHAN DRUG TAX CREDIT REVIVED

CYGNUS FILES IND FOR MULTIPLE-DOSE PATCHES

LIFECORE ACQUIRES DENTAL IMPLANT COMPANY

BIOMATRIX LICENSES EYE FLUID IN CANADA

AFFYMAX, ALZA FORMALIZE DEVELOPMENT PROGRAM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...